Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-26 · accession 0001867899-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-01 | 2025-11-26 | KNSA | Tessari Eben | COO | S - Sale+OE | $42.89 | -200 | 22.7K | -0.9% | -$8,578 |
| D | 2025-12-01 | 2025-11-26 | KNSA | Tessari Eben | COO | M - OptEx | $22.89 | +200 | 22.9K | +0.9% | +$4,578 |
| D | 2025-12-01 | 2025-11-26 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -200 | 46.9K | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-11-26 | S | D | 200 | $42.89 | 22,714 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-11-26 | M | A | 200 | $22.89 | 22,914 | D | — | — | |
| 3 | Derivative | Share Option | 2025-11-26 | M | D | 200 | $0.00 | 46,938 | D | $22.89 · — to 2031-03-15 | 200 Class A Ordinary Share | (F2) The option is fully vested and exercisable. |